Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Teladoc HealthTDOC |
-$76M |
 |
DoximityDOCS |
-$1.63B |
 |
Veeva SystemsVEEV |
-$517M |
 |
HealthequityHQY |
-$564M |
 |
McKessonMCK |
-$742M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Spectrum Equity VII, L.P. | Oct 15, 2025 | Sell | 15,202 | $4.0008 | $61,000 |
| Spectrum Equity VII, L.P. | Oct 15, 2025 | Sell | 8,569 | $4.0008 | $34,000 |
| Spectrum Equity VII, L.P. | Sep 5, 2025 | Sell | 10,243 | $4.05 | $41,000 |
| Spectrum Equity VII, L.P. | Sep 5, 2025 | Sell | 5,773 | $4.05 | $23,000 |
| Spectrum Equity VII, L.P. | Jul 3, 2025 | Sell | 6,828 | $4.7978 | $33,000 |
| Spectrum Equity VII, L.P. | Jul 3, 2025 | Sell | 3,849 | $4.7978 | $18,000 |
| Spectrum Equity VII, L.P. | Jun 6, 2025 | Sell | 6,828 | $4.0935 | $28,000 |
| Spectrum Equity VII, L.P. | Jun 6, 2025 | Sell | 3,849 | $4.0935 | $16,000 |
| Spectrum Equity VII, L.P. | Sep 3, 2024 | Sell | 6,828 | $7.8601 | $54,000 |
| Spectrum Equity VII, L.P. | Sep 3, 2024 | Sell | 3,849 | $7.8601 | $30,000 |
| Nabiey Romin | Aug 12, 2024 | Sell | 79,000 | $6.7674 | $530,000 |
| Wagner Scott | Nov 30, 2023 | Buy | 21,652 | $5.7642 | $120,000 |
| Wagner Scott | Nov 29, 2023 | Buy | 26,348 | $5.9011 | $160,000 |
| Wagner Scott | Nov 28, 2023 | Buy | 4,157 | $5.9996 | $25,000 |
| Wagner Scott | Nov 17, 2023 | Buy | 26,664 | $5.2607 | $140,000 |
| Wagner Scott | Nov 16, 2023 | Buy | 104,079 | $5.1615 | $540,000 |
What's the latest insider transaction for GoodRx?
The most recent insider transaction for GoodRx was conducted by Spectrum Equity VII, L.P., who sold 15,202 shares on October 15, 2025 at a price of $4.00 per share.
Which insider bought the most GDRX stock over the last two years?
Wagner Scott has bought the most GDRX stock in the last 2 years, with a total value of $980,000.
Which insider has sold the most GDRX stock over the last two years?
Nabiey Romin has sold the most GDRX stock in the last 2 years, with a total value of $530,000.
What is the total value of insider transactions for GoodRx (GDRX) in the last 2 years?
According to our estimates, the total value of insider transactions for GoodRx in the last 2 years is positive, amounting to $110,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on GoodRx's market confidence?
Over the last 2 years, insider transactions for GoodRx have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
